Clinical Trial Update: Obese Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for obese patients with type 2 diabetes has completed, sponsored by Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Sanofi | Conditions: Obesity, Diabetes Mellitus, Non-Insulin-Dependent | Phase 3 | Status: COMPLETED